1. Home
  2. ENZ vs INKT Comparison

ENZ vs INKT Comparison

Compare ENZ & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENZ
  • INKT
  • Stock Information
  • Founded
  • ENZ 1976
  • INKT 2017
  • Country
  • ENZ United States
  • INKT United States
  • Employees
  • ENZ N/A
  • INKT N/A
  • Industry
  • ENZ Medical Specialities
  • INKT Medicinal Chemicals and Botanical Products
  • Sector
  • ENZ Health Care
  • INKT Health Care
  • Exchange
  • ENZ Nasdaq
  • INKT Nasdaq
  • Market Cap
  • ENZ 34.2M
  • INKT 43.0M
  • IPO Year
  • ENZ N/A
  • INKT 2021
  • Fundamental
  • Price
  • ENZ $0.56
  • INKT $11.00
  • Analyst Decision
  • ENZ
  • INKT Strong Buy
  • Analyst Count
  • ENZ 0
  • INKT 2
  • Target Price
  • ENZ N/A
  • INKT $6.50
  • AVG Volume (30 Days)
  • ENZ 125.9K
  • INKT 71.7K
  • Earning Date
  • ENZ 03-12-2025
  • INKT 03-20-2025
  • Dividend Yield
  • ENZ N/A
  • INKT N/A
  • EPS Growth
  • ENZ N/A
  • INKT N/A
  • EPS
  • ENZ N/A
  • INKT N/A
  • Revenue
  • ENZ $30,314,000.00
  • INKT N/A
  • Revenue This Year
  • ENZ N/A
  • INKT N/A
  • Revenue Next Year
  • ENZ N/A
  • INKT N/A
  • P/E Ratio
  • ENZ N/A
  • INKT N/A
  • Revenue Growth
  • ENZ N/A
  • INKT N/A
  • 52 Week Low
  • ENZ $0.54
  • INKT $4.56
  • 52 Week High
  • ENZ $1.40
  • INKT $19.00
  • Technical
  • Relative Strength Index (RSI)
  • ENZ 28.08
  • INKT 59.75
  • Support Level
  • ENZ $0.56
  • INKT $7.32
  • Resistance Level
  • ENZ $0.69
  • INKT $13.79
  • Average True Range (ATR)
  • ENZ 0.03
  • INKT 2.07
  • MACD
  • ENZ 0.00
  • INKT 0.28
  • Stochastic Oscillator
  • ENZ 11.54
  • INKT 71.94

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Share on Social Networks: